Core Insights - Cullinan Therapeutics, Inc. is actively participating in investor conferences to enhance visibility and engagement with stakeholders [1][2] Company Overview - Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company focused on developing targeted therapies that are modality-agnostic [3] - The company has built a diversified portfolio of clinical-stage assets aimed at inhibiting key disease drivers and harnessing the immune system for treating autoimmune diseases and cancer [3] - Cullinan's approach includes rigorous candidate selection and development processes to fast-track promising therapeutic molecules [3] Upcoming Events - The CEO and CMO of Cullinan will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024 [1] - Additionally, they will engage in a fireside chat at the 2024 Cantor Global Healthcare Conference on September 19, 2024 [2] - Webcasts of these events will be available on the company's investor relations website [2]
Cullinan Therapeutics to Participate in Upcoming Investor Conferences